Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4457
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [31] COMPARING THE EFFICACY AND SAFETY OF BIOLOGICS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS: A NETWORK META-ANALYSIS
    Janssen, K. J.
    Medic, G.
    Broglio, K.
    Bergman, G.
    Berry, S.
    Sabater, F. J.
    Sennfalt, K.
    VALUE IN HEALTH, 2012, 15 (07) : A439 - A439
  • [32] Comparison of the Efficacy and Safety of Janus Kinase Inhibitors and DMARDs in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis
    Castro, Adela
    Diaz, Jesus
    Quiceno, Guillermo
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [33] Efficacy of Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis: A Meta-analysis and Systematic Review
    Zhang, Tony
    Timmerman, Nicholas
    Lau, Arthur
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 991 - 991
  • [34] Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis A Bayesian network meta-analysis of randomized controlled trials
    Lee, Y. H.
    Bae, S. -C.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (04): : 335 - 342
  • [35] COMPARATIVE EFFICACY AND SAFETY OF BARICITINIB 2 MG AND 4 MG IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lee, Y. H.
    Seo, Y. H.
    Song, G. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 285 - 285
  • [36] Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis
    Na Li
    Zhong-Ping Gou
    Shuang-Qing Du
    Xiao-Hong Zhu
    Hui Lin
    Xiu-Fang Liang
    Yong-Sheng Wang
    Ping Feng
    Clinical Rheumatology, 2022, 41 : 677 - 688
  • [37] The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis
    Qu, Bingjia
    Zhao, Feng
    Song, Ying
    Zhao, Junyi
    Yao, Yuxin
    Chen, Yulan
    Liao, Ruobing
    Fu, Lingyu
    PLOS ONE, 2024, 19 (06):
  • [38] SAFETY OF GLUCOCORTICOIDS FOR EARLY RHEUMATOID ARTHRITIS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
    Mitrovic, S.
    Fardet, L.
    Vatier, C.
    Barnetche, T.
    Schaeverbeke, T.
    Gaujoux-Viala, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 228 - 228
  • [39] Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
    Lee, Y. H.
    Song, G. G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (06): : 590 - 603
  • [40] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND UPADACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lee, Young Ho
    Song, Gwan Gyu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 751 - 751
12345